Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGES | O14684 | 9/20 | 0.49 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.47 |
| ▸ | CA7 | P43166 | 1/20 | 0.47 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.47 |
| ▸ | F2R | P25116 | 4/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | CNR2 | P34972 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | SMO | Q99835 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1750145 | 0.84 | TSHR (0.50) | HDAC6TSHRSMN1; SMN2HPGD | |
| SCHEMBL1751039 | 0.82 | TSHR (0.69) | TSHRSMN1; SMN2HPGD | |
| SCHEMBL29952190 | 0.82 | TSHR (0.54) | HDAC6CA1CA2TSHRSMN1; SMN2 | |
| SCHEMBL1750878 | 0.81 | TSHR (0.48) | TSHRSMN1; SMN2HPGD | |
| SCHEMBL15033692 | 0.81 | PTGES (0.52) | PTGESHDAC6CA1CA2CA7 | |
| SCHEMBL16181920 | 0.80 | PTGES (0.49) | PTGESHDAC6CA1CA2CA7 | |
| SCHEMBL16671183 | 0.80 | ERCC1 (0.56) | PTGESTSHR | |
| SCHEMBL671821 | 0.79 | CA1 (0.52) | PTGESHDAC6CA1CA2CA7 | |
| SCHEMBL16671197 | 0.79 | PTGES (0.51) | PTGESHDAC6CA1CA2CA7 | |
| SCHEMBL17199049 | 0.78 | PTGES (0.59) | PTGESHDAC6CA1CA2CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023127883-A1 | INDAZOLE COMPOUND AND PHARMACEUTICAL | 日本新薬株式会社 | 2023-07-06 | — | — | WO | disclosed |
| EP-3133068-B1 | AMIDE DERIVATIVES AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, PREPARATION METHOD THEREFOR AND MEDICINAL APPLICATION THEREOF | Shanghai hengrui pharmaceutical co ltd (CN) | 2020-11-25 | — | — | EP | disclosed |
| WO-2015059618-A1 | SUBSTITUTED PYRIMIDINE COMPOUNDS AS mPGES-1 INHIBITORS | GLENMARK PHARMACEUTICALS S.A. (CH) | 2015-04-30 | — | — | WO | disclosed |
| WO-2015059618-A1 | SUBSTITUTED PYRIMIDINE COMPOUNDS AS mPGES-1 INHIBITORS | GLENMARK PHARMACEUTICALS S.A. (CH) | 2015-04-30 | — | — | WO | disclosed |